There is going to be medicine

People are always anxious in finding the way of immortality.

There is going to be a rejuvenated medicine for the elderly

Aging always makes people worry, since feudal times people have been searching for immortality longevity remedies. Today, the medical science has made great strides in finding the elixir. The prospect of improving old people, immortality is gradually becoming a reality.

People are always anxious in finding the way of immortality.

The latest step in the process of searching for human immortality was announced last week at the Neurology Association Conference in Chicago, USA. Here, the researchers presented a research result, demonstrating that a conventional asthma drug with several ingredients could stimulate new rejuvenation and cell growth in the rat brain.

The research team, led by researcher Ludwig Aigner of the Paracelsus Salzburg School of Medicine, conducted a follow-up study on two groups of mice given regular, daily injections of montelukast (a drug used to treat asthma and It is also capable of blocking receptors associated with encephalitis.

Montelukast has the ability to block receptors associated with inflammatory diseases in the brain such as leukotrien.

Mice were divided into two groups, the first group consisted of 20 young mice (about seven months old) and the second group consisted of 14 old mice (about 20 months of age), the age of two groups of mice was equivalent to humans at age 20 and 60.

In a six-week skin test, two groups of mice underwent a series of memory tests for the researchers to monitor the effect of the drug on their ability to learn, such as finding an escape route after being fall into the water tank, of the mouse.

At the end of the trial, the team concluded that the drug did not affect the ability of young mice to learn. However, older mice injected with drugs may also be able to be similar to young mice in the trial."We have recovered 100% of the mouse's learning and memory ability, the ability of old mice is equivalent to young mice , " Aigner said.

Each year, neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntingson affect millions of people. The cause of these diseases is inflammation of the brain and nerve cells.Leukotrien receptors in the brain will cause inflammation if activated and scientists also discovered that these receptors are often concentrated in high concentrations on the parts of the neuronal region that are created.

After discovering the use of montelukast to block leukotrien receptors , Aigner and his colleagues thought about trying to see if it could fight inflammation and rejuvenate cells. The results were very encouraging, the number of old mice receiving anti-inflammatory montelukast was better than 80%, the blood-brain barrier was rejuvenated and the ability to develop new neurons was 50% higher than the small mice. than.

The good news is that this study will soon be clinically tested in humans because montelukast is widely used in the treatment of asthma. Aigner said the positive results of the study on mice will ensure clinical trials. He hopes to start research soon in Parkinson's patients because US law has allowed the use of leukotriene antagonists in these patients to combat neurodegeneration.